反応式
[F:1][C:2]([F:11])([F:10])[C:3]1[CH:4]=[N:5][CH:6]=[C:7](Br)[CH:8]=1.[CH3:12][C:13]1[N:14]=[C:15]([NH:18][C:19]([C:21]2[CH:26]=[C:25](B3OC(C)(C)C(C)(C)O3)[CH:24]=[C:23]([CH3:36])[N:22]=2)=[O:20])[S:16][CH:17]=1>>[CH3:12][C:13]1[N:14]=[C:15]([NH:18][C:19]([C:21]2[CH:26]=[C:25]([C:7]3[CH:6]=[N:5][CH:4]=[C:3]([C:2]([F:11])([F:10])[F:1])[CH:8]=3)[CH:24]=[C:23]([CH3:36])[N:22]=2)=[O:20])[S:16][CH:17]=1参加物
3
実験手順
The title compound, was prepared from 3-Trifluoromethyl-5-bromopyridine and 6-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxa-borolan-2-yl)-pyridine-2-carboxylic acid (4-methyl-thiazol-2-yl)-amide in accordance with the general method of example 1, step 6 to yield the final compound as a white solid, MS (ISP): m/e=379.2 (M+H)+.
出典と根拠
- ORDレコード
- ord-c8321f337ab9474b943419c693c60360
- 出典データセット
- uspto-grants-2011_05
- 特許番号
- US07951824B2
関連ノート
読み込み中…